XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.21%1.2B | 6.73%311.44M | 5.94%303.63M | 5.48%296.05M | 6.69%291.32M | 5.38%1.13B | 4.20%291.81M | 4.81%286.6M | 6.28%280.68M | 6.34%273.06M |
Operating revenue | 6.23%1.17B | 6.86%280.19M | 5.94%303.63M | 5.48%296.05M | 6.69%291.32M | 5.12%1.1B | 3.01%262.21M | 4.81%286.6M | 6.28%280.68M | 6.34%273.06M |
Cost of revenue | 7.91%391.8M | 6.54%101.95M | 9.07%99.95M | 7.03%94.18M | 9.06%95.72M | 1.77%363.1M | -0.28%95.69M | 0.03%91.64M | 6.74%87.99M | 1.15%87.77M |
Gross profit | 5.41%810.65M | 6.82%209.5M | 4.47%203.68M | 4.77%201.87M | 5.57%195.6M | 7.17%769.06M | 6.53%196.12M | 7.22%194.96M | 6.07%192.69M | 8.99%185.29M |
Operating expense | 5.33%392.34M | 6.72%101.94M | 3.13%97.85M | 6.88%97.14M | 4.64%95.41M | 4.91%372.47M | 2.98%95.52M | 5.18%94.88M | 3.20%90.89M | 8.53%91.18M |
Selling and administrative expenses | -1.91%49.74M | 13.12%14.82M | -17.70%10.82M | 1.50%12.09M | -4.30%12.01M | -3.66%50.71M | -3.61%13.1M | 0.37%13.15M | -12.43%11.91M | 1.64%12.55M |
-General and administrative expense | -1.91%49.74M | 13.12%14.82M | -17.70%10.82M | 1.50%12.09M | -4.30%12.01M | -3.66%50.71M | -3.61%13.1M | 0.37%13.15M | -12.43%11.91M | 1.64%12.55M |
Depreciation amortization depletion | 6.48%342.6M | 5.70%87.12M | 6.48%87.03M | 7.69%85.05M | 6.06%83.4M | 6.40%321.76M | 4.11%82.42M | 5.99%81.73M | 6.06%78.97M | 9.71%78.64M |
-Depreciation and amortization | 6.48%342.6M | 5.70%87.12M | 6.48%87.03M | 7.69%85.05M | 6.06%83.4M | 6.40%321.76M | 4.11%82.42M | 5.99%81.73M | 6.06%78.97M | 9.71%78.64M |
Operating profit | 5.48%418.32M | 6.92%107.56M | 5.74%105.83M | 2.88%104.73M | 6.47%100.19M | 9.39%396.59M | 10.14%100.6M | 9.23%100.08M | 8.76%101.8M | 9.45%94.11M |
Net non-operating interest income expense | -4.94%-171.18M | -0.93%-42.45M | -2.99%-43.26M | -6.92%-43.26M | -9.37%-42.21M | -20.02%-163.12M | -11.58%-42.06M | -20.61%-42.01M | -26.68%-40.46M | -22.70%-38.59M |
Non-operating interest income | -8.38%4.29M | -14.25%782K | 35.64%978K | -56.61%1.05M | 134.65%1.48M | 337.22%4.69M | 55.90%912K | 208.12%721K | 1,721.05%2.42M | 426.67%632K |
Non-operating interest expense | 4.57%175.48M | 0.61%43.23M | 3.54%44.24M | 3.33%44.31M | 11.39%43.69M | 22.50%167.81M | 12.26%42.97M | 21.87%42.73M | 33.70%42.88M | 24.24%39.23M |
Other net income (expense) | 316.00%57.2M | -63.82%3.1M | -32.37%888K | 3,094.29%53.19M | -98.56%32K | -91.87%13.75M | -86.65%8.55M | -98.71%1.31M | -40.71%1.67M | 1,025.89%2.22M |
Gain on sale of security | 446.91%54.04M | -78.48%1.76M | ---- | --52.28M | ---- | -89.43%9.88M | -64.61%8.18M | ---- | ---- | --1.7M |
Earnings from equity interest | -18.33%3.16M | 256.00%1.34M | -32.37%888K | -45.65%905K | -93.80%32K | -25.16%3.87M | 28.42%375K | -29.90%1.31M | -40.71%1.67M | 161.93%516K |
Special income (charges) | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Gain on sale of business | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Income before tax | 23.10%304.33M | 1.66%68.2M | 6.85%63.46M | 81.98%114.66M | 0.49%58.02M | -37.52%247.22M | -43.00%67.09M | -62.59%59.39M | -2.27%63M | 5.49%57.73M |
Income tax | ||||||||||
Net income | 23.10%304.33M | 1.66%68.2M | 6.85%63.46M | 81.98%114.66M | 0.49%58.02M | -37.52%247.22M | -43.00%67.09M | -62.59%59.39M | -2.27%63M | 5.49%57.73M |
Net income continuous Operations | 23.10%304.33M | 1.66%68.2M | 6.85%63.46M | 81.98%114.66M | 0.49%58.02M | -37.52%247.22M | -43.00%67.09M | -62.59%59.39M | -2.27%63M | 5.49%57.73M |
Minority interest income | -10.81%9.13M | -10.78%2.67M | 7.00%2.51M | 6.71%2.67M | -46.58%1.28M | 0.61%10.23M | 49.42%2.99M | -11.08%2.34M | -10.25%2.51M | -12.68%2.4M |
Net income attributable to the parent company | 24.57%295.21M | 2.24%65.54M | 6.85%60.95M | 85.10%111.98M | 2.53%56.74M | -38.52%236.99M | -44.59%64.1M | -63.46%57.05M | -1.91%60.5M | 6.45%55.34M |
Preferred stock dividends | 0.00%8.03M | 0.00%2.01M | 0.00%2.01M | 0.00%2.01M | 0.00%2.01M | -0.02%8.03M | 0.00%2.01M | 0.00%2.01M | 0.00%2.01M | -0.10%2.01M |
Other preferred stock dividends | -0.23%1.28M | -3.16%1.29M | ||||||||
Net income attributable to common stockholders | 25.58%285.89M | 2.36%62.25M | 7.09%58.95M | 88.02%109.97M | 2.63%54.73M | -39.47%227.67M | -45.88%60.81M | -64.29%55.04M | -1.97%58.49M | 6.71%53.33M |
Basic earnings per share | 22.14%3.42 | -1.32%0.75 | 4.48%0.7 | 83.33%1.32 | 1.54%0.66 | -40.55%2.8 | -45.71%0.76 | -64.74%0.67 | -4.00%0.72 | 3.17%0.65 |
Diluted earnings per share | 22.14%3.42 | -1.32%0.75 | 4.48%0.7 | 83.33%1.32 | 1.54%0.66 | -40.55%2.8 | -45.71%0.76 | -64.55%0.67 | -4.00%0.72 | 3.17%0.65 |
Dividend per share | 0.92%4.38 | 0.92%1.1 | 0.92%1.1 | 0.93%1.09 | 0.93%1.09 | 0.93%4.34 | 0.93%1.09 | 0.93%1.09 | 0.93%1.08 | 0.93%1.08 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |